4th Annual Advances in Immuno-Oncology Congress

20 – 21 May 2019∣London, UK

 

Oxford Global is proud to present the 4th Annual Advances in Immuno-Oncology Congress taking place on 20 – 21 May 2019 in London, UK. Across the two days, expert speakers will provide you with a forward-looking perspective on the opportunities and challenges impacting market growth in immuno-oncology. A revamped programme for 2019 ensures you gain a comprehensive look at immuno-oncology drug development from early discovery through to the clinic.

 

Featuring 6 interactive streams:

• Discovery of Immuno-Oncology Therapies
• Preclinical Development
• Translational Immuno-Oncology
• Precision Medicine and Personalised Therapy
• Genomics in Cancer Immunotherapy
• Immuno-Oncology Clinical Research and Clinical Trials

 

View the agenda: https://bit.ly/2xO4qBb

 

Over 60 presentations will provide the latest case studies across key therapeutic areas such as T-cell therapy, bispecific antibodies, cancer vaccines, checkpoint inhibitors and microbiome-based therapeutics. Further talks look at genomic strategies for cancer immunotherapy, as well as personalising cancer treatments. To enhance the interactivity of the programme, we have also incorporated an increased amount of discussion opportunities through panels, roundtables and workshops on hot topics in the field.

 

Key Speakers include Directors from MSD, Novartis, MedImmune, AstraZeneca and many more. The two-day congress offers an interactive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions. It will bring together over 350 senior industry experts and key opinion leaders in immuno-oncology.

 

For more information about the programme and registration, please contact Angela Fernandez Saez at a.saez@oxfordglobal.co.uk.